NCT07679555 Hemodynamic, Laboratory, and Clinical Outcomes of Hemoadsorption Therapy
| NCT ID | NCT07679555 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Pest County Flór Ferenc Hospital |
| Condition | Hemoadsorption |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2020-01-01 |
| Primary Completion | 2026-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60 participants in total. It began in 2020-01-01 with a primary completion date of 2026-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This single-center retrospective observational cohort study aims to evaluate the clinical, hemodynamic, and laboratory effects of adjunctive hemoadsorption therapy in critically ill adult patients treated in the Intensive Care Unit of Flór Ferenc Hospital, Hungary, between January 1, 2020, and May 31, 2026. Patients who received CytoSorb® or Efferon LPS® hemoadsorption therapy will be included. The study will assess changes in vasopressor requirements, hemodynamic parameters, inflammatory biomarkers, liver function tests, tissue perfusion markers, and oxygenation following hemoadsorption treatment. Clinical outcomes, including intensive care unit length of stay, all-cause mortality occurring during the patient's stay in the intensive care unit (ICU mortality), and 28-day and 90-day mortality, will also be evaluated. Data will be collected retrospectively from anonymized medical records, and no study-related interventions will be performed.
Eligibility Criteria
Inclusion Criteria: * \>18 years; * CytoSorb or Efferon LPS hemoadsorption treatment, * with available relevant pre- and post-treatment clinical and laboratory data Exclusion Criteria: * age under 18 years * missing key demographic or outcome data; * unknown treatment type or timing; * data unavailable for legal or ethical reasons.
Contact & Investigator
Zoltán Ruszkai, MD, PhD
STUDY DIRECTOR
Pest County Flór Ferenc Hospital
Frequently Asked Questions
Who can join the NCT07679555 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hemoadsorption. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07679555 currently recruiting?
Yes, NCT07679555 is actively recruiting participants. Contact the research team at ruszkai.zoltan@florhosp.hu for enrollment information.
Where is the NCT07679555 trial being conducted?
This trial is being conducted at Kistarcsa, Hungary.
Who is sponsoring the NCT07679555 clinical trial?
NCT07679555 is sponsored by Pest County Flór Ferenc Hospital. The principal investigator is Zoltán Ruszkai, MD, PhD at Pest County Flór Ferenc Hospital. The trial plans to enroll 60 participants.